Načítá se...
Cyclophosphamide in Multiple Sclerosis: Scientific Rationale, History and Novel Treatment Paradigms
For patients with relapsing—remitting multiple sclerosis (RRMS), there are currently six approved medications that have been shown to alter the natural course of the disease. The approved medications include three beta interferon formulations, glatiramer acetate, natalizumab and mitoxantrone. Treati...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002608/ https://ncbi.nlm.nih.gov/pubmed/21180630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285609344375 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|